Maiden Pharmaceuticals, linked to cough syrups associated with child deaths in Gambia, denied tampering with test samples or bribing officials. An investigation by the state of Haryana's Food and Drug Administration is probing whether a state drug regulator was bribed to switch samples tested by the Indian government, contradicting WHO findings.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/grQ7px1
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Maiden Pharma denies tampering with tests in probe of cough syrup deaths
0 comments:
Post a Comment